{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T20:19:46Z","timestamp":1767903586803,"version":"3.49.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T00:00:00Z","timestamp":1553904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Biotechnology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.tibtech.2019.03.013","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T20:03:10Z","timestamp":1555444990000},"page":"1202-1216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Production and Biomedical Application of Flavivirus-like Particles"],"prefix":"10.1016","volume":"37","author":[{"given":"Ewelina","family":"Krol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Brzuska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boguslaw","family":"Szewczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tibtech.2019.03.013_bb0005","series-title":"Molecular Biology of the\u00a0Flavivirus","first-page":"1","article-title":"1 - The molecular biology of yellow fever virus","author":"K\u00fcmmerer","year":"2006"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0010","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.nbt.2017.07.010","article-title":"Production of virus-like particles for vaccines","volume":"39","author":"Fuenmayor","year":"2017","journal-title":"New Biotechnol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0015","series-title":"Arthropod Borne Diseases","first-page":"73","article-title":"Flavivirus","author":"Contigiani","year":"2017"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0020","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1128\/JVI.76.11.5480-5491.2002","article-title":"Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum","volume":"76","author":"Lorenz","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrmicro1067","article-title":"A structural perspective of the Flavivirus life cycle","volume":"3","author":"Mukhopadhyay","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0030","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.mi.44.100190.003245","article-title":"Flavivirus genome organization, expression, and replication","volume":"44","author":"Chambers","year":"1990","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/0470058005.ch3","article-title":"Molecular biology of flaviviruses","volume":"277","author":"Harris","year":"2006","journal-title":"Novartis Found. Symp."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.virol.2016.06.022","article-title":"Enhancing dengue virus maturation using a stable furin over-expressing cell line","volume":"497","author":"Mukherjee","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0045","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/1471-2334-14-246","article-title":"Distinguishing West Nile virus infection using a recombinant envelope protein with mutations in the conserved fusion-loop","volume":"14","author":"Chabierski","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0050","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2471\/BLT.10.085233","article-title":"Estimated global incidence of Japanese encephalitis: a systematic review","volume":"89","author":"Campbell","year":"2011","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0055","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1080\/21645515.2017.1285472","article-title":"Japanese encephalitis vaccines: immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease","volume":"13","author":"Hegde","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004686","article-title":"Low protective efficacy of the current Japanese encephalitis vaccine against the emerging genotype 5 Japanese encephalitis virus","volume":"10","author":"Cao","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0065","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/0042-6822(92)90526-U","article-title":"Mice immunized with a subviral particle containing the Japanese encephalitis virus prM\/M and E proteins are protected from lethal JEV infection","volume":"188","author":"Konishi","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0070","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1128\/JVI.75.5.2204-2212.2001","article-title":"Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles","volume":"75","author":"Konishi","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0075","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1472-6750-14-62","article-title":"Generation and characterization of a new mammalian cell line continuously expressing virus-like particles of Japanese encephalitis virus for a subunit vaccine candidate","volume":"14","author":"Hua","year":"2014","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0080","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0166-0934(01)00346-9","article-title":"A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen","volume":"97","author":"Hunt","year":"2001","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0085","doi-asserted-by":"crossref","first-page":"8745","DOI":"10.1128\/JVI.77.16.8745-8755.2003","article-title":"Stable high-producer cell clone expressing virus-like particles of the Japanese encephalitis virus E protein for a second-generation subunit vaccine","volume":"77","author":"Kojima","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1128\/CVI.05412-11","article-title":"Poly-\u03b3-glutamic acid nanoparticles and aluminum adjuvant used as an adjuvant with a single dose of Japanese encephalitis virus-like particles provide effective protection from Japanese encephalitis virus","volume":"19","author":"Okamoto","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/srep28688","article-title":"Bivalent vaccine platform based on Japanese encephalitis virus (JEV) elicits neutralizing antibodies against JEV and hepatitis C virus","volume":"6","author":"Saga","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1743-422X-4-17","article-title":"Expression of particulate-form of Japanese encephalitis virus envelope protein in a stably transfected Drosophila cell line","volume":"4","author":"Zhang","year":"2007","journal-title":"Virol. J."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0105","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jbiosc.2012.06.012","article-title":"Production of Japanese encephalitis virus-like particles using the baculovirus\u2013insect cell system","volume":"114","author":"Yamaji","year":"2012","journal-title":"J.\u00a0Biosci. Bioeng."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0110","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00253-012-4371-y","article-title":"Efficient production of Japanese encephalitis virus-like particles by recombinant lepidopteran insect cells","volume":"97","author":"Yamaji","year":"2013","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0115","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1099\/vir.0.000052","article-title":"Glycoprotein E of the Japanese encephalitis virus forms virus-like particles and induces syncytia when expressed by a baculovirus","volume":"96","author":"Du","year":"2015","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0120","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/376230","article-title":"The global ecology and epidemiology of West Nile virus","volume":"2015","author":"Chancey","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0125","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/infdis\/jiq003","article-title":"Phase II, randomized, double-blind, placebo-controlled, multicenter study to investigate the immunogenicity and safety of a West Nile virus vaccine in healthy adults","volume":"203","author":"Biedenbender","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0130","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.3390\/v5123048","article-title":"Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virus","volume":"5","author":"Dayan","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0135","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1086\/425933","article-title":"Induction of sterilizing immunity against West Nile virus (WNV), by immunization with WNV-like particles produced in insect cells","volume":"190","author":"Qiao","year":"2004","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0140","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1016\/j.vaccine.2010.07.055","article-title":"Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate","volume":"28","author":"Ohtaki","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0145","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.virol.2016.06.006","article-title":"Production of immunogenic West Nile virus-like particles using a herpes simplex\u00a0virus 1 recombinant vector","volume":"496","author":"Taylor","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0150","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1743-422X-7-146","article-title":"A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice","volume":"7","author":"Spohn","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0155","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s12033-014-9743-3","article-title":"Mosaic RNA phage VLPs carrying domain III of the West Nile virus E protein","volume":"56","author":"Cielens","year":"2014","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0160","doi-asserted-by":"crossref","first-page":"7852","DOI":"10.1073\/pnas.1607931113","article-title":"Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus","volume":"113","author":"Priyamvada","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1126\/science.aal4365","article-title":"Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity","volume":"356","author":"Bardina","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0170","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ni.3515","article-title":"Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with Zika virus","volume":"17","author":"Dejnirattisai","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0175","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.immuni.2019.01.005","article-title":"Dengue virus immunity increases Zika virus-induced damage during pregnancy","volume":"50","author":"Brown","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0180","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0042-6822(02)00028-4","article-title":"Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus","volume":"306","author":"Chang","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0185","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.virol.2004.12.036","article-title":"Secretion of noninfectious dengue virus-like particles and identification of amino acids in the stem region involved in intracellular retention of envelope protein","volume":"333","author":"Purdy","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0190","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.1128\/JVI.01963-09","article-title":"The length of and nonhydrophobic residues in the transmembrane domain of dengue virus envelope protein are critical for its retention and assembly in the endoplasmic reticulum","volume":"84","author":"Hsieh","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0195","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.virol.2007.12.041","article-title":"A strong endoplasmic reticulum retention signal in the stem\u2013anchor region of envelope glycoprotein of dengue virus type 2 affects the production of virus-like particles","volume":"374","author":"Hsieh","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0200","doi-asserted-by":"crossref","first-page":"33149","DOI":"10.1074\/jbc.M114.610428","article-title":"Highly conserved residues in the helical domain of dengue virus type 1 precursor membrane protein are involved in assembly, precursor membrane (prM) protein cleavage, and entry","volume":"289","author":"Hsieh","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0205","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01181-17","article-title":"An envelope-modified tetravalent dengue virus-like-particle vaccine has implications for Flavivirus vaccine design","volume":"91","author":"Urakami","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0210","doi-asserted-by":"crossref","first-page":"7728","DOI":"10.1016\/j.vaccine.2018.10.072","article-title":"Dengue-2 virus-like particle (VLP) based vaccine elicits the highest titers of neutralizing antibodies when produced at reduced temperature","volume":"36","author":"Boigard","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0215","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12866-014-0233-3","article-title":"Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties","volume":"14","author":"Liu","year":"2014","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0220","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4269\/ajtmh.16-0503","article-title":"Recombinant dengue virus 4 envelope glycoprotein virus-like particles derived from Pichia pastoris are capable of eliciting homotypic domain III-directed neutralizing antibodies","volume":"96","author":"Khetarpal","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064595","article-title":"Pichia pastoris-expressed dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies","volume":"8","author":"Mani","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0230","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12896-016-0280-y","article-title":"Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies","volume":"16","author":"Poddar","year":"2016","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0235","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3389\/fmicb.2015.01005","article-title":"Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies","volume":"6","author":"Tripathi","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0240","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.3389\/fmicb.2017.02644","article-title":"Pichia pastoris-expressed bivalent virus-like particulate vaccine induces domain III-focused bivalent neutralizing antibodies without antibody-dependent enhancement in\u00a0vivo","volume":"8","author":"Shukla","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0245","doi-asserted-by":"crossref","first-page":"8643","DOI":"10.1038\/s41598-018-26904-5","article-title":"Dengue envelope-based \u2018four-in-one\u2019 virus-like particles produced using Pichia pastoris induce enhancement-lacking, domain III-directed tetravalent neutralising antibodies in mice","volume":"8","author":"Rajpoot","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0250","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.vaccine.2012.12.016","article-title":"Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice","volume":"31","author":"Arora","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006191","article-title":"A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice","volume":"12","author":"Ramasamy","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0260","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00253-015-6973-7","article-title":"Tests in mice of a dengue vaccine candidate made of chimeric Junin virus-like particles and conserved dengue virus envelope sequences","volume":"100","author":"Mareze","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0265","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1743-422X-10-129","article-title":"A novel platform for virus-like particle-display of flaviviral envelope domain III: induction of dengue and West Nile virus neutralizing antibodies","volume":"10","author":"Chua","year":"2013","journal-title":"Virol. J."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0270","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0035-9203(52)90042-4","article-title":"Zika virus (I). Isolations and serological specificity","volume":"46","author":"Dick","year":"1952","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0275","series-title":"Zika Situation Report","author":"WHO","year":"2017"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005608","article-title":"Zika virus-like particle (VLP) based vaccine","volume":"11","author":"Boigard","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0285","article-title":"Immunization with truncated envelope protein of Zika virus induces protective immune response in mice","volume":"7","author":"Han","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0290","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00576-17","article-title":"Recombinant Zika virus subunits are immunogenic and efficacious in mice","volume":"3","author":"To","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0295","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1126\/science.aai9137","article-title":"Rapid development of a DNA vaccine for Zika virus","volume":"354","author":"Dowd","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0300","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nature18952","article-title":"Vaccine protection against Zika virus from Brazil","volume":"536","author":"Larocca","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0305","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.aah6157","article-title":"Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys","volume":"353","author":"Abbink","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0310","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1038\/s41467-018-04859-5","article-title":"Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors","volume":"9","author":"L\u00f3pez-Camacho","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0315","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","article-title":"Modified mRNA vaccines protect against Zika virus infection","volume":"168","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0320","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41467-018-02975-w","article-title":"Development of a chimeric Zika vaccine using a licensed live-attenuated Flavivirus vaccine as backbone","volume":"9","author":"Li","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0325","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(17)33106-9","article-title":"Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials","volume":"391","author":"Modjarrad","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0330","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00834-17","article-title":"Development of virus like particle vaccine and reporter assay for Zika virus","volume":"91","author":"Garg","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006210","article-title":"Zika virus like particles elicit protective antibodies in mice","volume":"12","author":"Salvo","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0340","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.chom.2016.04.013","article-title":"Structures of the Zika virus envelope protein and its complex with a Flavivirus broadly protective antibody","volume":"19","author":"Dai","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0345","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12250-018-0030-5","article-title":"Zika virus baculovirus-expressed virus-like particles induce neutralizing antibodies in mice","volume":"33","author":"Dai","year":"2018","journal-title":"Virol. Sin."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0350","doi-asserted-by":"crossref","first-page":"E365","DOI":"10.3390\/v10070365","article-title":"Establishment of baculovirus-expressed VLPs induced syncytial formation assay for Flavivirus antiviral screening","volume":"10","author":"Dai","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0355","doi-asserted-by":"crossref","first-page":"7679","DOI":"10.1038\/s41598-017-08247-9","article-title":"Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0360","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/imr.12367","article-title":"Fc receptors in antibody-dependent enhancement of viral infections","volume":"268","author":"Taylor","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0365","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1126\/science.1185181","article-title":"Cross-reacting antibodies enhance dengue virus infection in humans","volume":"328","author":"Dejnirattisai","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0370","doi-asserted-by":"crossref","first-page":"11800","DOI":"10.1128\/JVI.05237-11","article-title":"A fusion-loop antibody enhances the infectious properties of immature Flavivirus particles","volume":"85","author":"Rodenhuis-Zybert","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0375","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1016\/j.vaccine.2015.09.108","article-title":"Development of the Sanofi Pasteur tetravalent dengue vaccine: one more step forward","volume":"33","author":"Guy","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0380","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1473-3099(17)30752-1","article-title":"Dengvaxia: age as surrogate for serostatus","volume":"18","author":"Aguiar","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0385","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.4049\/jimmunol.144.8.3183","article-title":"Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection","volume":"144","author":"Littaua","year":"1990","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0390","doi-asserted-by":"crossref","first-page":"10128","DOI":"10.1128\/JVI.00792-06","article-title":"Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human Fcgamma RIA (CD64) or FcgammaRIIA (CD32)","volume":"80","author":"Rodrigo","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0395","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1128\/JVI.00216-15","article-title":"Dengue virus infection with highly neutralizing levels of cross-reactive antibodies causes acute lethal small intestinal pathology without a high level of viremia in mice","volume":"89","author":"Watanabe","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0400","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jmb.2018.02.006","article-title":"Crystal structure of the capsid protein from Zika virus","volume":"430","author":"Shang","year":"2018","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0405","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1128\/JVI.06796-11","article-title":"Dengue virus capsid protein binding to hepatic lipid droplets (LD) is potassium ion dependent and is mediated by LD surface proteins","volume":"86","author":"Carvalho","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000632","article-title":"Dengue virus capsid protein usurps lipid droplets for viral particle formation","volume":"5","author":"Samsa","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0415","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1099\/vir.0.037721-0","article-title":"Recombinant nucleocapsid-like particles from dengue-2 induce functional serotype-specific cell-mediated immunity in mice","volume":"93","author":"Gil","year":"2012","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0420","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00705-009-0350-8","article-title":"In\u00a0vitro assembly of nucleocapsid-like particles from purified recombinant capsid protein of dengue-2 virus","volume":"154","author":"L\u00f3pez","year":"2009","journal-title":"Arch. Virol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0425","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1128\/JVI.00447-16","article-title":"Membrane anchors of the structural Flavivirus proteins and their role in virus assembly","volume":"90","author":"Blazevic","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0430","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1093\/emboj\/cdg270","article-title":"Structures of immature Flavivirus particles","volume":"22","author":"Zhang","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0435","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.virol.2010.10.033","article-title":"Human monoclonal antibodies to West Nile virus identify epitopes on the prM protein","volume":"410","author":"Calvert","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0440","doi-asserted-by":"crossref","first-page":"5917","DOI":"10.1007\/s00253-015-6538-9","article-title":"Comprehensive mapping infection-enhancing epitopes of dengue pr protein using polyclonal antibody against prM","volume":"99","author":"Luo","year":"2015","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0445","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1128\/JVI.73.7.5605-5612.1999","article-title":"Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E","volume":"73","author":"Allison","year":"1999","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0450","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/femsre\/fuu004","article-title":"Receptors and routes of dengue virus entry into the host cells","volume":"39","author":"Cruz-Oliveira","year":"2015","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0455","doi-asserted-by":"crossref","first-page":"11567","DOI":"10.1128\/JVI.05859-11","article-title":"Poorly neutralizing cross-reactive antibodies against the fusion loop of\u00a0West Nile virus envelope protein protect in\u00a0vivo\u00a0via\u00a0Fc\u03b3 receptor and complement-dependent\u00a0effector mechanisms","volume":"85","author":"Vogt","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0460","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S1286-4579(02)01647-7","article-title":"Reactivity of serum samples from patients with a Flavivirus infection measured by immunofluorescence assay and ELISA","volume":"4","author":"Koraka","year":"2002","journal-title":"Microbes Infect."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0465","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s12250-009-3023-6","article-title":"A virus-type specific serological diagnosis of Flavivirus infection using virus-like particles","volume":"24","author":"Qing","year":"2009","journal-title":"Virol. Sin."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0470","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jviromet.2009.05.016","article-title":"Establishment of a neutralization test involving reporter gene-expressing virus-like particles of tick-borne encephalitis virus","volume":"161","author":"Yoshii","year":"2009","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.tibtech.2019.03.013_bb0475","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12985-018-0970-2","article-title":"Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope","volume":"15","author":"Metz","year":"2018","journal-title":"Virol. J."},{"key":"10.1016\/j.tibtech.2019.03.013_bb0480","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1128\/CVI.00004-08","article-title":"Enzyme-linked immunosorbent assays using novel Japanese encephalitis virus antigen improve the accuracy of clinical diagnosis of Flavivirus infections","volume":"15","author":"Chiou","year":"2008","journal-title":"Clin. Vaccine Immunol."}],"container-title":["Trends in Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779919300721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779919300721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T04:47:48Z","timestamp":1759121268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167779919300721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":96,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0167779919300721"],"URL":"https:\/\/doi.org\/10.1016\/j.tibtech.2019.03.013","relation":{},"ISSN":["0167-7799"],"issn-type":[{"value":"0167-7799","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Production and Biomedical Application of Flavivirus-like Particles","name":"articletitle","label":"Article Title"},{"value":"Trends in Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tibtech.2019.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}